There seems to be cognitive dissonance in the air here and I say...

There seems to be cognitive dissonance in the air here and I say this as a shareholder and with clients heavily invested. The price we paid to rush the PFS is becoming more evident. LOM and various optimizations are lacking and we’re trying to plug in the gaps.

There is definitely a delay in the BFS and mid 2020 doesn’t give us 24 months. The letter states the obvious- in complex processing projects you need to complete bulk test work. The market has raised this question re COB before. So we’re looking at a delay and extra costs = this has translated into a 20% share price haircut.

Have you seen any announcements indicating director buying ? I haven’t.

The directors own nothing of this company. When they start buying we’ve reached something like fair value. If they issue themselves options now I’m going to raise an issue.